Search:
Wednesday, Nov-20 2019 13:18 WIB
  • AGRI 1,386.120 6.670 (0.484%)
  • BASIC-IND 960.600 -5.720 (-0.592%)
  • BISNIS-27 544.830 0.780 (0.143%)
  • COMPOSITE 6,147.070 -5.020 (-0.082%)
  • CONSUMER 2,061.480 -6.760 (-0.327%)
  • DBX 1,102.700 -4.890 (-0.442%)
  • FINANCE 1,280.940 1.910 (0.149%)
  • I-GRADE 173.800 0.440 (0.254%)
  • IDX30 537.730 0.480 (0.089%)
  • IDX80 139.690 -0.010 (-0.007%)
  • IDXBUMN20 382.860 0.230 (0.060%)
  • IDXG30 141.740 0.190 (0.134%)
  • IDXHIDIV20 488.220 0.480 (0.098%)
  • IDXSMC-COM 257.200 -0.470 (-0.182%)
  • IDXSMC-LIQ 312.200 -0.630 (-0.201%)
  • IDXV30 139.750 -0.200 (-0.143%)
  • INFOBANK15 980.470 2.250 (0.230%)
  • INFRASTRUC 1,137.540 4.140 (0.365%)
  • Investor33 457.840 0.010 (0.002%)
  • ISSI 185.820 -0.320 (-0.172%)
  • JII 685.660 -1.390 (-0.202%)
  • JII70 231.800 -0.350 (-0.151%)
  • KOMPAS100 1,246.090 -0.130 (-0.010%)
  • LQ45 986.660 0.760 (0.077%)
  • MANUFACTUR 1,446.080 -6.160 (-0.424%)
  • MBX 1,713.990 -0.530 (-0.031%)
  • MINING 1,484.070 -1.500 (-0.101%)
  • MISC-IND 1,175.400 -4.560 (-0.386%)
  • MNC36 340.150 -0.250 (-0.073%)
  • PEFINDO25 338.770 2.820 (0.839%)
  • PROPERTY 502.850 -1.930 (-0.382%)
  • SMinfra18 320.080 -0.350 (-0.109%)
  • SRI-KEHATI 388.930 0.330 (0.085%)
  • TOTAL_MARKET 6,147.070 -5.020 (-0.082%)
  • TRADE 781.340 -0.900 (-0.115%)
  • © 2010 IMQ - LKBN ANTARA
  • AALI 12,600 0 (0.00%)
  • ABBA 117 -7 (-5.65%)
  • ABMM 1,355 0 (0.00%)
  • ACES 1,645 5 (0.30%)
  • ACST 1,110 -10 (-0.89%)
  • ADES 1,070 0 (0.00%)
  • ADHI 1,220 5 (0.41%)
  • ADMF 10,525 50 (0.48%)
  • ADMG 192 0 (0.00%)
  • ADRO 1,325 5 (0.38%)
  • AGII 590 5 (0.85%)
  • AGRO 190 1 (0.53%)
  • AGRS 178 2 (1.14%)
  • AHAP 63 -1 (-1.56%)
  • AKKU 50 0 (0.00%)
  • AKRA 3,710 30 (0.82%)
  • AKSI 800 5 (0.63%)
  • ALDO 382 2 (0.53%)
  • ALKA 510 0 (0.00%)
  • ALMI 320 22 (7.38%)
  • ALTO 380 -8 (-2.06%)
  • AMFG 3,440 -10 (-0.29%)
  • AMIN 276 -14 (-4.83%)
  • AMRT 875 0 (0.00%)
  • ANDI 153 6 (4.08%) © 2010 IMQ - LKBN ANTARA
  • ANTM 830 -5 (-0.60%)
  • APEX 352 -52 (-12.87%)
  • APIC 665 15 (2.31%)
  • APLI 140 -1 (-0.71%)
  • APLN 192 -4 (-2.04%)
  • ARKA 1,560 10 (0.65%)
  • ARMY 63 3 (5.00%)
  • ARNA 470 -20 (-4.08%)
  • ARTA 360 4 (1.12%)
  • ARTI 50 0 (0.00%)
  • ARTO 2,240 -610 (-21.40%)
  • ASGR 955 0 (0.00%)
  • ASII 6,625 -25 (-0.38%)
  • ASJT 180 -9 (-4.76%)
  • ASMI 945 -5 (-0.53%)
  • ASRI 258 0 (0.00%)
  • ASSA 745 20 (2.76%)
  • AUTO 1,270 10 (0.79%)
  • BABP 50 0 (0.00%)
  • BABP-W3 43 11 (34.38%)
  • BAJA 69 -1 (-1.43%)
  • BAPA 77 4 (5.48%)
  • BAPI 50 0 (0.00%)
  • BAPI-W 5 0 (0.00%)
  • BATA 665 15 (2.31%) © 2010 IMQ - LKBN ANTARA
  • BAYU 1,215 -385 (-24.06%)
  • BBCA 31,675 100 (0.32%)
  • BBHI 160 -9 (-5.33%)
  • BBKP 248 -2 (-0.80%)
  • BBLD 426 0 (0.00%)
  • BBNI 7,625 25 (0.33%)
  • BBRI 4,210 20 (0.48%)
  • BBTN 2,090 20 (0.97%)
  • BCAP 147 -1 (-0.68%)
  • BCIP 81 0 (0.00%)
  • BDMN 3,980 70 (1.79%)
  • BEEF 374 2 (0.54%)
  • BEEF-W 41 0 (0.00%)
  • BEKS 50 0 (0.00%)
  • BELL 520 0 (0.00%)
  • BEST 212 -2 (-0.93%)
  • BFIN 570 -10 (-1.72%)
  • BGTG 66 1 (1.54%)
  • BHIT 69 1 (1.47%)
  • BIKA 200 6 (3.09%)
  • BIMA 50 0 (0.00%)
  • BINA 840 -5 (-0.59%)
  • BIPI 50 0 (0.00%)
  • BIPI-W 11 -1 (-8.33%)
  • BIPP 72 4 (5.88%) © 2010 IMQ - LKBN ANTARA
  • BIRD 2,090 -60 (-2.79%)
  • BISI 1,090 0 (0.00%)
  • BJBR 1,585 -20 (-1.25%)
  • BJTM 685 -15 (-2.14%)
  • BKDP 54 -1 (-1.82%)
  • BKSL 106 -1 (-0.93%)
  • BKSL-W 19 -1 (-5.00%)
  • BKSW 155 1 (0.65%)
  • BLUE 505 5 (1.00%)
  • BMAS 314 0 (0.00%)
  • BMRI 7,125 -25 (-0.35%)
  • BMSR 139 21 (17.80%)
  • BMTR 396 0 (0.00%)
  • BNBA 310 -6 (-1.90%)
  • BNBR 50 0 (0.00%)
  • BNGA 960 5 (0.52%)
  • BNII 216 2 (0.93%)
  • BNLI 1,050 15 (1.45%)
  • BOGA 875 15 (1.74%)
  • BOLA 362 4 (1.12%)
  • BOLT 815 -5 (-0.61%)
  • BOSS 212 19 (9.84%)
  • BPFI 1,285 80 (6.64%)
  • BPTR 95 0 (0.00%)
  • BRIS 368 -2 (-0.54%) © 2010 IMQ - LKBN ANTARA
  • BRMS 54 2 (3.85%)
  • BRNA 1,095 -5 (-0.45%)
  • BRPT 1,190 -55 (-4.42%)
  • BRPT-W 700 -110 (-13.58%)
  • BSDE 1,375 -15 (-1.08%)
  • BSIM-W3 45 18 (66.67%)
  • BSSR 1,820 -10 (-0.55%)
  • BTEK 50 0 (0.00%)
  • BTON 200 8 (4.17%)
  • BTPN 3,190 10 (0.31%)
  • BTPS 3,820 10 (0.26%)
  • BUDI 100 0 (0.00%)
  • BULL 182 -1 (-0.55%)
  • BULL-W2 25 0 (0.00%)
  • BUMI 77 0 (0.00%)
  • BUVA 78 -1 (-1.27%)
  • BVIC 165 -2 (-1.20%)
  • BWPT 95 3 (3.26%)
  • CAKK 74 -1 (-1.33%)
  • CAKK-W 21 -1 (-4.55%)
  • CAMP 370 -2 (-0.54%)
  • CANI 150 -3 (-1.96%)
  • CARS 202 -6 (-2.88%)
  • CASA 370 -2 (-0.54%)
  • CCSI 254 4 (1.60%) © 2010 IMQ - LKBN ANTARA
  • CEKA 1,580 30 (1.94%)
  • CENT 65 1 (1.56%)
  • CFIN 270 0 (0.00%)
  • CINT 242 -10 (-3.97%)
  • CITA 1,890 -10 (-0.53%)
  • CITY 121 -44 (-26.67%)
  • CITY-W 30 0 (0.00%)
  • CLAY 4,490 0 (0.00%)
  • CLEO 525 0 (0.00%)
  • CLPI 775 -10 (-1.27%)
  • CMNP 1,825 0 (0.00%)
  • CNKO 50 0 (0.00%)
  • CNTX 390 16 (4.28%)
  • COCO 880 -10 (-1.12%)
  • COCO-W 300 -180 (-37.50%)
  • COWL 91 -26 (-22.22%)
  • CPIN 7,325 175 (2.45%)
  • CPRI 50 -1 (-1.96%)
  • CPRI-W 26 0 (0.00%)
  • CPRO 50 0 (0.00%)
  • CSAP 448 0 (0.00%)
  • CSIS 96 3 (3.23%)
  • CTRA 1,075 -5 (-0.46%)
  • CTTH 69 1 (1.47%)
  • DAYA 290 2 (0.69%) © 2010 IMQ - LKBN ANTARA
  • DEFI 1,770 -5 (-0.28%)
  • DEWA 50 0 (0.00%)
  • DFAM 392 -8 (-2.00%)
  • DIGI 1,700 -50 (-2.86%)
  • DILD 328 0 (0.00%)
  • DIVA 3,760 80 (2.17%)
  • DKFT 170 -1 (-0.58%)
  • DLTA 6,650 -50 (-0.75%)
  • DMAS 316 -8 (-2.47%)
  • DMMX 262 -2 (-0.76%)
  • DNET 3,060 -10 (-0.33%)
  • DOID 282 -4 (-1.40%)
  • DPUM 109 -1 (-0.91%)
  • DSFI 106 -1 (-0.93%)
  • DSNG 414 -2 (-0.48%)
  • DUCK 1,375 -30 (-2.14%)
  • DVLA 2,230 10 (0.45%)
  • DWGL 312 -12 (-3.70%)
  • DWGL-W 113 -4 (-3.42%)
  • DYAN 115 -1 (-0.86%)
  • EAST 114 23 (25.27%)
  • EAST-W 14 2 (16.67%)
  • EKAD 950 0 (0.00%)
  • ELSA 304 0 (0.00%)
  • ENRG 52 1 (1.96%) © 2010 IMQ - LKBN ANTARA
  • ENVY 880 -290 (-24.79%)
  • ERAA 1,565 0 (0.00%)
  • ESIP 565 30 (5.61%)
  • ESIP-W 89 -10 (-10.10%)
  • ESSA 286 -2 (-0.69%)
  • ESTI 77 4 (5.48%)
  • ETWA 65 -3 (-4.41%)
  • EXCL 3,510 -20 (-0.57%)
  • FAST 2,700 -100 (-3.57%)
  • FASW 7,450 0 (0.00%)
  • FILM 187 4 (2.19%)
  • FIRE 1,265 -65 (-4.89%)
  • FISH 2,600 0 (0.00%)
  • FITT 50 0 (0.00%)
  • FITT-W 10 -1 (-9.09%)
  • FOOD 96 0 (0.00%)
  • FPNI 120 -5 (-4.00%)
  • FREN 141 0 (0.00%)
  • FREN-W 72 2 (2.86%)
  • FUJI 104 1 (0.97%)
  • GAMA 50 0 (0.00%)
  • GDST 68 -5 (-6.85%)
  • GGRM 53,875 225 (0.42%)
  • GGRP 550 -10 (-1.79%)
  • GHON 1,300 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • GIAA 555 0 (0.00%)
  • GJTL 625 0 (0.00%)
  • GMFI 165 0 (0.00%)
  • GOOD 1,500 -5 (-0.33%)
  • GPRA 86 2 (2.38%)
  • GTBO 172 14 (8.86%)
  • GWSA 177 0 (0.00%)
  • GZCO 50 0 (0.00%)
  • HDIT 725 -5 (-0.68%)
  • HEAL 3,660 -20 (-0.54%)
  • HELI-W 15 0 (0.00%)
  • HERO 820 -10 (-1.20%)
  • HEXA 3,670 190 (5.46%)
  • HITS 452 22 (5.12%)
  • HKMU 316 -2 (-0.63%)
  • HMSP 2,060 0 (0.00%)
  • HOKI 920 -5 (-0.54%)
  • HOME 50 0 (0.00%)
  • HOTL 157 -3 (-1.88%)
  • HRME 1,030 0 (0.00%)
  • HRTA 292 -2 (-0.68%)
  • HRUM 1,350 -10 (-0.74%)
  • IATA 50 0 (0.00%)
  • IBFN-W 31 1 (3.33%)
  • ICBP 11,400 -25 (-0.22%) © 2010 IMQ - LKBN ANTARA
  • ICON 80 8 (11.11%)
  • IGAR 342 2 (0.59%)
  • IIKP 50 0 (0.00%)
  • IKAI 137 -2 (-1.44%)
  • IKBI 264 2 (0.76%)
  • IMAS 1,220 -15 (-1.21%)
  • IMJS 288 -4 (-1.37%)
  • IMPC 1,030 -5 (-0.48%)
  • INAF 930 -5 (-0.53%)
  • INCF 50 0 (0.00%)
  • INCI 412 -14 (-3.29%)
  • INCO 3,250 -50 (-1.52%)
  • INDF 7,925 -25 (-0.31%)
  • INDR 3,280 0 (0.00%)
  • INDS 2,570 30 (1.18%)
  • INDX 62 2 (3.33%)
  • INDY 1,260 0 (0.00%)
  • INKP 7,875 -50 (-0.63%)
  • INOV 406 -2 (-0.49%)
  • INPC 67 0 (0.00%)
  • INPC-W 7 -1 (-12.50%)
  • INPP 830 -30 (-3.49%)
  • INRU 825 0 (0.00%)
  • INTD 388 -20 (-4.90%)
  • INTP 19,800 -175 (-0.88%) © 2010 IMQ - LKBN ANTARA
  • IPCC 695 -15 (-2.11%)
  • IPCM 195 -3 (-1.52%)
  • IPOL 98 0 (0.00%)
  • IPTV 510 0 (0.00%)
  • IPTV-W 97 0 (0.00%)
  • IRRA 500 0 (0.00%)
  • ISAT 3,190 10 (0.31%)
  • ISSP 216 2 (0.93%)
  • ITIC 1,045 -5 (-0.48%)
  • ITMA 620 0 (0.00%)
  • ITMA-W 64 5 (8.47%)
  • ITMG 12,050 0 (0.00%)
  • JAST 2,220 -10 (-0.45%)
  • JAYA 87 1 (1.16%)
  • JAYA-W 22 2 (10.00%)
  • JGLE 50 0 (0.00%)
  • JPFA 1,710 20 (1.18%)
  • JRPT 570 -5 (-0.87%)
  • JSKY 234 -78 (-25.00%)
  • JSMR 5,175 -25 (-0.48%)
  • JTPE 935 110 (13.33%)
  • KAEF 2,150 10 (0.47%)
  • KARW 70 3 (4.48%)
  • KAYU 107 7 (7.00%)
  • KBLI 550 -5 (-0.90%) © 2010 IMQ - LKBN ANTARA
  • KBLM 328 24 (7.89%)
  • KBLV 290 -50 (-14.71%)
  • KDSI 1,190 -10 (-0.83%)
  • KEEN 565 -5 (-0.88%)
  • KIAS 81 -4 (-4.71%)
  • KICI 400 0 (0.00%)
  • KIJA 322 0 (0.00%)
  • KINO 3,690 -10 (-0.27%)
  • KIOS-W 298 0 (0.00%)
  • KJEN 2,000 0 (0.00%)
  • KKGI 232 6 (2.65%)
  • KLBF 1,520 0 (0.00%)
  • KMTR 322 -2 (-0.62%)
  • KOBX 127 3 (2.42%)
  • KOIN 150 0 (0.00%)
  • KOPI 620 0 (0.00%)
  • KOTA 625 10 (1.63%)
  • KOTA-W 74 1 (1.37%)
  • KPAL 545 -5 (-0.91%)
  • KPAS 66 -4 (-5.71%)
  • KPAS-W 27 3 (12.50%)
  • KPIG 123 -1 (-0.81%)
  • KRAH 1,140 10 (0.88%)
  • KRAS 290 -2 (-0.68%)
  • KREN 505 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • LAND 1,300 -25 (-1.89%)
  • LIFE 5,500 0 (0.00%)
  • LION 525 29 (5.85%)
  • LMAS 50 0 (0.00%)
  • LMPI 104 1 (0.97%)
  • LPCK 1,210 0 (0.00%)
  • LPIN 260 -14 (-5.11%)
  • LPKR 254 -2 (-0.78%)
  • LPPF 3,550 -10 (-0.28%)
  • LPPS 86 -1 (-1.15%)
  • LRNA 130 0 (0.00%)
  • LSIP 1,330 20 (1.53%)
  • LTLS 655 10 (1.55%)
  • LUCK 480 -25 (-4.95%)
  • MABA 50 0 (0.00%)
  • MAIN 1,105 45 (4.25%)
  • MAMI 264 14 (5.60%)
  • MAMI-W 56 6 (12.00%)
  • MAPI 1,065 10 (0.95%)
  • MARI 197 -3 (-1.50%)
  • MARK 470 2 (0.43%)
  • MASA 362 2 (0.56%)
  • MBAP 2,000 20 (1.01%)
  • MBSS 496 -2 (-0.40%)
  • MCAS 3,170 10 (0.32%) © 2010 IMQ - LKBN ANTARA
  • MCOR 133 0 (0.00%)
  • MDIA 68 1 (1.49%)
  • MDKA 1,035 15 (1.47%)
  • MDKI 200 -2 (-0.99%)
  • MDLN 218 -2 (-0.91%)
  • MEDC 650 -5 (-0.76%)
  • MEDC-W 122 7 (6.09%)
  • MEGA 5,600 -150 (-2.61%)
  • MERK 2,970 0 (0.00%)
  • META 190 -4 (-2.06%)
  • MFMI 480 44 (10.09%)
  • MGRO 915 -30 (-3.17%)
  • MIKA 2,800 80 (2.94%)
  • MINA 1,200 -140 (-10.45%)
  • MKNT 50 0 (0.00%)
  • MLBI 16,500 50 (0.30%)
  • MLIA 1,150 35 (3.14%)
  • MLPL 73 0 (0.00%)
  • MMLP 300 0 (0.00%)
  • MNCN 1,415 -5 (-0.35%)
  • MPMX 695 5 (0.72%)
  • MPOW 135 6 (4.65%)
  • MPPA 142 -5 (-3.40%)
  • MRAT 151 -4 (-2.58%)
  • MREI 4,190 -510 (-10.85%) © 2010 IMQ - LKBN ANTARA
  • MSIN 456 0 (0.00%)
  • MSKY 965 45 (4.89%)
  • MTDL 1,800 -35 (-1.91%)
  • MTFN 50 0 (0.00%)
  • MTPS 1,250 35 (2.88%)
  • MTPS-W 880 10 (1.15%)
  • MTRA 336 0 (0.00%)
  • MTWI 70 0 (0.00%)
  • MYOH 1,270 0 (0.00%)
  • MYOR 2,180 -20 (-0.91%)
  • MYRX 50 0 (0.00%)
  • NASA 645 5 (0.78%)
  • NATO 710 25 (3.65%)
  • NELY 148 0 (0.00%)
  • NFCX 3,130 30 (0.97%)
  • NIKL 820 -35 (-4.09%)
  • NIRO 140 0 (0.00%)
  • NISP 825 0 (0.00%)
  • NOBU 930 10 (1.09%)
  • NRCA 384 -2 (-0.52%)
  • NUSA 50 0 (0.00%)
  • NUSA-W 9 1 (12.50%)
  • NZIA 1,080 -15 (-1.37%)
  • NZIA-W 210 10 (5.00%)
  • OCAP 278 20 (7.75%) © 2010 IMQ - LKBN ANTARA
  • OKAS 183 -5 (-2.66%)
  • OPMS 131 0 (0.00%)
  • PAMG 109 0 (0.00%)
  • PANI 109 0 (0.00%)
  • PANR 336 -2 (-0.59%)
  • PANS 1,485 -5 (-0.34%)
  • PBID 1,025 0 (0.00%)
  • PBRX 665 -20 (-2.92%)
  • PBSA 312 2 (0.65%)
  • PCAR 1,470 -230 (-13.53%)
  • PEHA 1,020 -5 (-0.49%)
  • PGAS 2,000 -10 (-0.50%)
  • PGLI 179 10 (5.92%)
  • PICO 3,670 90 (2.51%)
  • PJAA 1,065 -5 (-0.47%)
  • PKPK 68 -2 (-2.86%)
  • PLIN 2,980 -220 (-6.88%)
  • PNBN 1,245 15 (1.22%)
  • PNBS 50 0 (0.00%)
  • PNIN 1,125 5 (0.45%)
  • PNLF 276 -2 (-0.72%)
  • POLA 1,010 -70 (-6.48%)
  • POLI 1,600 230 (16.79%)
  • POLL 8,150 50 (0.62%)
  • POLU 1,795 295 (19.67%) © 2010 IMQ - LKBN ANTARA
  • POLY 56 1 (1.82%)
  • POOL 910 -250 (-21.55%)
  • PORT 500 0 (0.00%)
  • POSA 54 -2 (-3.57%)
  • POSA-W 6 1 (20.00%)
  • POWR 1,080 0 (0.00%)
  • PPRE 244 -4 (-1.61%)
  • PPRO 95 0 (0.00%)
  • PRDA 3,960 -10 (-0.25%)
  • PRIM 280 -18 (-6.04%)
  • PRIM-W 39 -1 (-2.50%)
  • PSAB 258 0 (0.00%)
  • PSDN 120 -20 (-14.29%)
  • PSSI 172 -2 (-1.15%)
  • PTBA 2,470 -10 (-0.40%)
  • PTPP 1,575 -15 (-0.94%)
  • PTRO 1,670 15 (0.91%)
  • PTSN 306 -2 (-0.65%)
  • PURE 360 -120 (-25.00%)
  • PURE-W 103 -36 (-25.90%)
  • PWON 605 10 (1.68%)
  • PZZA 1,180 10 (0.85%)
  • RAJA 206 -4 (-1.90%)
  • RALS 1,080 -20 (-1.82%)
  • RANC 348 8 (2.35%) © 2010 IMQ - LKBN ANTARA
  • RBMS 76 3 (4.11%)
  • RDTX 5,200 50 (0.97%)
  • RIGS 238 0 (0.00%)
  • RIMO 54 2 (3.85%)
  • RISE 650 0 (0.00%)
  • RMBA 352 10 (2.92%)
  • RODA 115 5 (4.55%)
  • ROTI 1,310 -5 (-0.38%)
  • RUIS 248 8 (3.33%)
  • SAFE 200 1 (0.50%)
  • SAME 236 -6 (-2.48%)
  • SATU 80 0 (0.00%)
  • SCMA 1,350 40 (3.05%)
  • SDMU 50 0 (0.00%)
  • SFAN 920 0 (0.00%)
  • SGRO 2,410 90 (3.88%)
  • SHIP 790 -5 (-0.63%)
  • SIDO 1,215 0 (0.00%)
  • SILO 7,000 0 (0.00%)
  • SIMA 50 0 (0.00%)
  • SIMP 370 6 (1.65%)
  • SINI 985 60 (6.49%)
  • SINI-W 530 25 (4.95%)
  • SKBM 418 0 (0.00%)
  • SKRN 525 -20 (-3.67%) © 2010 IMQ - LKBN ANTARA
  • SKYB 65 -6 (-8.45%)
  • SLIS 4,630 -70 (-1.49%)
  • SMAR 3,710 10 (0.27%)
  • SMBR 490 0 (0.00%)
  • SMCB 1,285 -15 (-1.15%)
  • SMDR 256 0 (0.00%)
  • SMGR 12,400 -25 (-0.20%)
  • SMKL 212 -6 (-2.75%)
  • SMKL-W 23 0 (0.00%)
  • SMMT 125 2 (1.63%)
  • SMRA 1,100 -15 (-1.35%)
  • SMRU 50 0 (0.00%)
  • SMSM 1,380 -20 (-1.43%)
  • SOCI 202 4 (2.02%)
  • SOSS-W 57 -30 (-34.48%)
  • SOTS 176 -23 (-11.56%)
  • SOTS-W 74 -3 (-3.90%)
  • SPMA 322 2 (0.62%)
  • SPTO 975 0 (0.00%)
  • SQMI 228 -2 (-0.87%)
  • SRAJ 244 0 (0.00%)
  • SRIL 258 -4 (-1.53%)
  • SRSN 66 -2 (-2.94%)
  • SRTG 3,810 -10 (-0.26%)
  • SSIA 700 10 (1.45%) © 2010 IMQ - LKBN ANTARA
  • SSMS 855 -5 (-0.58%)
  • STAR 102 1 (0.99%)
  • SULI 50 0 (0.00%)
  • SWAT 107 0 (0.00%)
  • TALF 380 -38 (-9.09%)
  • TAMU 480 0 (0.00%)
  • TARA 720 -10 (-1.37%)
  • TAXI 50 0 (0.00%)
  • TBIG 1,070 -15 (-1.38%)
  • TBLA 870 0 (0.00%)
  • TBMS 990 -5 (-0.50%)
  • TCPI 5,100 0 (0.00%)
  • TDPM 230 2 (0.88%)
  • TEBE 1,790 20 (1.13%)
  • TELE 302 6 (2.03%)
  • TFAS 173 3 (1.76%)
  • TGRA 158 -52 (-24.76%)
  • TINS 795 -5 (-0.62%)
  • TIRA 250 0 (0.00%)
  • TIRT 58 0 (0.00%)
  • TKIM 12,025 -175 (-1.43%)
  • TLKM 4,060 40 (1.00%)
  • TMAS 114 0 (0.00%)
  • TNCA 250 0 (0.00%)
  • TOBA 360 0 (0.00%) © 2010 IMQ - LKBN ANTARA
  • TOPS 530 -10 (-1.85%)
  • TOTL 424 2 (0.47%)
  • TOTO 296 0 (0.00%)
  • TOWR 660 0 (0.00%)
  • TPIA 9,425 -25 (-0.26%)
  • TRAM 54 3 (5.88%)
  • TRAM-W 28 5 (21.74%)
  • TRIM 149 0 (0.00%)
  • TRIS 254 2 (0.79%)
  • TRUK 108 0 (0.00%)
  • TRUS 330 56 (20.44%)
  • TSPC 1,415 5 (0.35%)
  • ULTJ 1,665 -25 (-1.48%)
  • UNIT 184 -2 (-1.08%)
  • UNSP 95 0 (0.00%)
  • UNTR 22,375 -75 (-0.33%)
  • UNVR 42,400 -400 (-0.93%)
  • URBN 2,230 -20 (-0.89%)
  • URBN-W 49 5 (11.36%)
  • VICO 108 0 (0.00%)
  • VINS 125 -7 (-5.30%)
  • VINS-W 14 0 (0.00%)
  • VIVA 70 -1 (-1.41%)
  • VOKS 278 -4 (-1.42%)
  • WEGE 306 -2 (-0.65%) © 2010 IMQ - LKBN ANTARA
  • WEHA 147 0 (0.00%)
  • WIIM 178 -3 (-1.66%)
  • WIKA 1,990 -10 (-0.50%)
  • WINS 125 0 (0.00%)
  • WOMF 284 0 (0.00%)
  • WOOD 680 -5 (-0.73%)
  • WOWS 414 -6 (-1.43%)
  • WSBP 320 -2 (-0.62%)
  • WSKT 1,435 -15 (-1.03%)
  • WTON 418 -2 (-0.48%)
  • XCID 77 1 (1.32%)
  • XCIS 106 0 (0.00%)
  • XIIF 639 4 (0.63%)
  • XIIT 549 0 (0.00%)
  • XISC 710 0 (0.00%)
  • XISR 398 8 (2.05%)
  • XSBC 111 3 (2.78%)
  • YELO 97 1 (1.04%)
  • YELO-W 21 -1 (-4.55%)
  • YPAS 510 22 (4.51%)
  • ZINC 372 0 (0.00%)
  • ZONE 456 -2 (-0.44%)
Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD
Published: 5 Nov 2019 14:21 WIB


IMQ, Jakarta —  Transaction further accelerates deleveraging

Strengthens alignment of Growth & Emerging Markets Business Unit portfolio with Takeda’s global business areas

OSAKA, Japan--(Antara/BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG (“STADA”), an international pharmaceutical company, for a total value of $660 million USD. The portfolio includes over-the-counter (OTC) and prescription pharmaceutical products exclusively in Russia, Georgia, and a number of countries from within the Commonwealth of Independent States, which form part of Takeda’s Growth & Emerging Markets Business Unit.

This is Takeda’s fourth divestment transaction in the past six months that contributes to the Company’s goal to divest approximately $10 billion USD in non-core assets to focus on its five key business areas and commitment to accelerating its deleveraging following its acquisition of Shire. Takeda completed the divestiture of Xiidra® to Novartis for up to $5.3 billion USD in July, announced the sale of TachoSil® to Ethicon for $400 million USD in May, and last month announced its sale of non-core assets in countries spanning Near East, Middle East and Africa to Acino for over $200 million USD.

“This announcement is the latest step in Takeda’s effort to simplify our portfolio, accelerate deleveraging, and continue to invest in our key business areas. We are making strong progress towards executing our strategy and delivering enhanced value for patients and Takeda shareholders,” said Costa Saroukos, Chief Financial Officer, Takeda.

The portfolio to be divested to STADA includes OTC Vitamins and Food Supplements, plus select products within the Cardiovascular, Diabetes, General Medicine, and Respiratory therapeutic areas. The portfolio’s growth is driven by sales of products such as Cardiomagnyl, and other strong regional brands. Combined, the portfolio of products to be divested to STADA and Acino generated revenues of approximately $300 million USD in fiscal year 2018.

While these trusted products continue to play important roles in meeting patient needs, they are not within Takeda's chosen business areas – Gastroenterology, Rare Diseases, Plasma-Derived Therapies, Oncology and Neuroscience – that are core to its global long-term growth.

“Takeda remains committed to the Emerging Markets, Russia and the countries included in this agreement. We will continue to increase patient access to our portfolio of highly innovative medicines across this region through our commercial activities and Access to Medicines program,” said Ricardo Marek, President, Growth & Emerging Markets Business Unit, Takeda. “As we execute on our divestiture goals, we continue to work to ensure that each transaction aligns with Takeda’s values. We are confident that STADA is well placed to provide patients with uninterrupted access to the divested products – a top priority for Takeda – and anticipate most of the employees supporting the divested assets will be given the opportunity to transition over to STADA once the divestiture is completed.”

Takeda intends to use the proceeds from this divestiture to continue to reduce its debt and accelerate deleveraging toward its target of 2.0x net debt/adjusted EBITDA over the next three to five years. Takeda is committed to rapid deleveraging driven by strong cash flow and divestiture proceeds, while also simplifying its portfolio.

Transaction Details

Takeda has entered into an agreement to sell a portfolio of approximately 20 select OTC and prescription pharmaceutical assets sold in Russia, Georgia and countries within the Commonwealth of Independent States namely: Armenia, Azerbaijan, Belarus, Kazakhstan, and Uzbekistan to STADA – an international pharmaceutical company with a two-pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer health products – for a total value of $660 million USD. Under the terms of the agreement, STADA will acquire the rights, title, and interest to the products in the portfolio exclusive to these countries.

It is anticipated that approximately 500 employees supporting the divested assets will be given the opportunity to transition over to STADA at closing. Further, Takeda and STADA will enter into manufacturing and supply agreements under which Takeda will continue to manufacture and supply the products to STADA.

The transaction is expected to close in Q4 FY19 (January- March 2020), subject to the satisfaction of customary closing conditions. Until then, the products will continue to be made avaliable to patients and manufactured and supplied by Takeda.

Takeda is being advised by BofA Securities (financial advisor) and White & Case (legal advisor) in this transaction.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

For more information, visit https://www.takeda.com

Forward-Looking Statements

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. Forward-looking statements in this document are based on Takeda’s estimates and assumptions only as of the date hereof. Such forward-looking statements do not represent any guarantee by Takeda or its management of future performance and involve known and unknown risks, uncertainties and other factors, including but not limited to: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the timing and impact of post-merger integration efforts with acquired companies; and the ability to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s), any of which may cause Takeda’s actual results, performance, achievements or financial position to be materially different from any future results, performance, achievements or financial position expressed or implied by such forward-looking statements. For more information on these and other factors which may affect Takeda’s results, performance, achievements, or financial position, see “Item 3. Key Information—D. Risk Factors” in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/reports/sec-filings/ or at www.sec.gov. Future results, performance, achievements or financial position of Takeda could differ materially from those expressed in or implied by the forward-looking statements. Persons receiving this press release should not rely unduly on any forward-looking statements. Takeda undertakes no obligation to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results of Takeda in this press release may not be indicative of, and are not an estimate, forecast or projection of Takeda’s future results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191104006136/en/

Contacts
Investor Relations:
Takashi Okubo
+81-(0)3-3278-2306
takeda.ir.contact@takeda.com

Media Inquiries:
Sandy Rodriguez
Head, Integration & Divestiture Communications
sandy.rodriguez@takeda.com

Vince Docherty
Head, Communications, GEM Business Unit
vince.docherty@Takeda.com

Kazumi Kobayashi (Japan)
+81 (0)3-3278-2095
kazumi.kobayashi@takeda.com

Source: Takeda Pharmaceutical Company Limited
Author: Business Wire
-
POPULAR NEWS